Characteristics and outcomes of immunotherapy-related liver injury in patients with hepatocellular carcinoma versus other advanced solid tumours

Immune-related liver injury(irLI) is commonly observed in patients with cancer treated with immune checkpoint inhibitors(ICIs). We aimed to compare incidence, clinical characteristics and outcomes of irLI between patients receiving ICIs for hepatocellular carcinoma(HCC) versus other solid tumours.

Source: Journal of Hepatology - November 14, 2023 Category: Gastroenterology Authors: Ciro Celsa, Giuseppe Cabibbo, Claudia AM Fulgenzi, Bernhard Scheiner, Antonio d ’Alessio, Giulia F. Manfredi, Naoshi Nishida, Celina Ang, Thomas U. Marron, Anwaar Saeed, Brooke Wietharn, Matthias Pinter, Jaekyung Cheon, Yi-Hsiang Huang, Pei-Chang Lee, Tags: Research Article Source Type: research